TARRYTOWN, N.Y., Dec. 19, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management presentations at the 33(rd) Annual J.P. Morgan Healthcare Conference as follows:


    --  Panel discussion "Harnessing the Power of Next Gen Sequencing - The View
        From Industry" on Monday, January 12, 2015 at 5:00 p.m. Pacific Time
        (8:00 p.m. Eastern Time)
    --  Company presentation on Tuesday, January 13, 2015 at 10:30 a.m. Pacific
        Time (1:30 p.m. Eastern Time)

Both webcasts may be accessed through the Company's web site, www.regeneron.com, on the 'Events and Presentations' page. Archived versions of the presentations will be available for 30 days.

About Regeneron Pharmaceuticals, Inc.
 Regeneron is a leading science-based biopharmaceutical company based in Tarrytown, New York that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Regeneron commercializes medicines for eye diseases, colorectal cancer, and a rare inflammatory condition and has product candidates in development in other areas of high unmet medical need, including hypercholesterolemia, oncology, rheumatoid arthritis, asthma, and atopic dermatitis. Several Regeneron programs are based on human genetic findings. For additional information about the company, please visit www.regeneron.com.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/regeneron-announces-presentation-at-the-33rd-annual-jp-morgan-healthcare-conference-300010337.html



    Contact Information:


    Investor Relations            Corporate Communications

    Michael Aberman               Hala Mirza

    914.847.7799                  914.847.3422

    michael.aberman@regeneron.com hala.mirza@regeneron.com
    -----------------------------

SOURCE Regeneron Pharmaceuticals, Inc.